Hemmo Latvala

Hemmo Latvala serves as CTO at TrueMed. TrueMed operates in the pharmaceuticals sector with approximately 40.0 employees. The company is headquartered in Helsinki, Uusimaa.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 1,221 executive contacts are available in Uusimaa.
• • Our database includes 201,469 c suite-level executives.

Gmail Google Apps SAP Data Analytics Android Basis Circle Remote AI

artificial intelligence machine vision protection pharmaceutical manufacturing counterfeit detection ai technology digital forensic lab investigator tools product returns brand protection pharmaceutical safety mobile app verification real-time data analysis anti-counterfeit solutions image analysis machine learning supply chain security fraud prevention non-additive technology instant verification smartphone scanning forensic intelligence scalable platform data analytics automated reporting mobile device compatibility product authenticity grievance management custom integration dynamic protection strategies field investigations quality assurance user role management effective inspection counterfeit grouping market intelligence alert system digital archive healthcare products regulatory compliance efficient workflow fraudulent returns detection education & training comprehensive data gathering fast analysis digital capture devices cost-effective solutions intellectual property protection track & trace customer engagement brand reputation counterfeit medicine identification multi-layer authentication information technology & services pharmaceuticals medical

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Hemmo Latvala in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at TrueMed.

Hemmo Latvala's Position in the MessageCEO Database

• •Hemmo Latvala is 1 of 1 verified executive contact we track at TrueMed.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •1,214 verified executive contacts in Uusimaa are in the database.
• •8 verified contacts work at pharmaceuticals companies in the 40.0 employee range (same size as TrueMed).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Hemmo Latvala directly?

Hemmo Latvala's verified email address is available to MessageCEO Pro subscribers. They currently serve as CTO at TrueMed. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Hemmo Latvala work for?

Hemmo Latvala is CTO at TrueMed, a company in the pharmaceuticals sector with 40.0 employees. The company is based in Helsinki, Uusimaa.

Can I pitch or sell to Hemmo Latvala?

As CTO at TrueMed, Hemmo Latvala is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Hemmo Latvala directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Hemmo Latvala in?

Hemmo Latvala works in the pharmaceuticals industry as CTO at TrueMed. MessageCEO provides verified contact information for executives across all major industries.

Is Hemmo Latvala's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Hemmo Latvala's profile is kept up-to-date with the latest available information.

Last updated: June 22, 2026